Mouse renal 4T1 cell engraftment as a model to study the influence of hypoxia in breast cancer progression (2013)
- Autores:
- Autores USP: TIÉZZI, DANIEL GUIMARÃES - FMRP ; ANDRADE, JURANDYR MOREIRA DE - FMRP
- Unidade: FMRP
- DOI: 10.1590/S0102-86502013000200010
- Assuntos: MODELOS ANIMAIS; NEOPLASIAS MAMÁRIAS; METÁSTASE NEOPLÁSICA; RATOS
- Idioma: Inglês
- Imprenta:
- Fonte:
- Título do periódico: Acta Cirúrgica Brasileira
- ISSN: 0102-8650
- Volume/Número/Paginação/Ano: v. 28, n. 1, p. 142-147, 2013
- Este periódico é de acesso aberto
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: gold
- Licença: cc-by
-
ABNT
ANTONIO, Heriton Marcelo Ribeiro et al. Mouse renal 4T1 cell engraftment as a model to study the influence of hypoxia in breast cancer progression. Acta Cirúrgica Brasileira, v. 28, n. 1, p. 142-147, 2013Tradução . . Disponível em: https://doi.org/10.1590/S0102-86502013000200010. Acesso em: 24 abr. 2024. -
APA
Antonio, H. M. R., Mandarano, L. R. M., Coelho, A. A., Tiezzi, M. G., Andrade, J. M. de, & Tiezzi, D. G. (2013). Mouse renal 4T1 cell engraftment as a model to study the influence of hypoxia in breast cancer progression. Acta Cirúrgica Brasileira, 28( 1), 142-147. doi:10.1590/S0102-86502013000200010 -
NLM
Antonio HMR, Mandarano LRM, Coelho AA, Tiezzi MG, Andrade JM de, Tiezzi DG. Mouse renal 4T1 cell engraftment as a model to study the influence of hypoxia in breast cancer progression [Internet]. Acta Cirúrgica Brasileira. 2013 ; 28( 1): 142-147.[citado 2024 abr. 24 ] Available from: https://doi.org/10.1590/S0102-86502013000200010 -
Vancouver
Antonio HMR, Mandarano LRM, Coelho AA, Tiezzi MG, Andrade JM de, Tiezzi DG. Mouse renal 4T1 cell engraftment as a model to study the influence of hypoxia in breast cancer progression [Internet]. Acta Cirúrgica Brasileira. 2013 ; 28( 1): 142-147.[citado 2024 abr. 24 ] Available from: https://doi.org/10.1590/S0102-86502013000200010 - Expression of hypoxia-inducible factor 1-'alfa' and vascular endothelial growth factor-C in locally advanced breast cancer patients
- Volume of breast tissue excised during breast-conserving surgery in patients undergoing preoperative systemic therapy
- Expression of aldehyde dehydrogenase after neoadjuvant chemotherapy is associated with expression of hypoxia-inducible factors 1 and 2 alpha and predicts prognosis in locally advanced breast cancer
- Recurrence and survival after neoadjuvant chemotherapy for locally advanced cervical cancer is dependent on the pathological response
- Development of new formulations of biologics: expectations, immunogenicity, and safety for subcutaneous trastuzumab
- Treatment for low-risk gestational trophoblastic disease: comparison of single-agent methotrexate, dactnomycin and combination regimens
- Primary adenocarcinoma of the fallopian tube as an incidental finding during surgery in a postmenopausal patient with unspecific pelvic pain
- Safety and efficacy of gemcitabine plus cisplatin combination in pretreated metastatic breast cancer patients
- Germ cells and mammary gland transcritome comparison generate a powerful gene expression profile that predicts breast cancer survival
- Dose-response association of CD8+ tumor-infiltrating lymphocytes and survival time in high-grade serous ovarian cancer
Informações sobre o DOI: 10.1590/S0102-86502013000200010 (Fonte: oaDOI API)
Download do texto completo
| Tipo | Nome | Link | |
|---|---|---|---|
 | 002448036.pdf | Direct link |
Como citar
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
